Literature DB >> 2085801

Renal catabolism of human glucagon-like peptides 1 and 2.

C Ruiz-Grande1, J Pintado, C Alarcón, C Castilla, I Valverde, J M López-Novoa.   

Abstract

The renal catabolism of [125I]glucagon-like peptide 1 (GLP-1) and [125I]glucagon-like peptide 2 (GLP-2) has been studied both in vivo, by the disappearance of these peptides from the plasma of bilaterally nephrectomized (BNX), ureteral-ligated (BUL) or normal rats, and in vitro, analyzing their catabolism by the isolated, perfused rat kidney. Results from in vivo studies demonstrated that half-disappearance time for both peptides was lower in controls than in BUL rats, and this value in BUL rats was not significantly different from that in BNX rats. In addition, metabolic clearance rate of GLP-1 was higher in control rats than in the other two groups of animals. Urinary clearance rate of both peptides was negligible. In isolated kidney experiments, values for organ clearance of both [125I]GLP-1 and [125I]GLP-2 were similar to those of inulin clearance, which represents the glomerular filtration rate. Urinary clearance of trichloroacetic acid precipitable radioactivity represented less than 1% of total clearance. In conclusion, these results demonstrate a significant role for the kidney in the plasma removal of [125I]GLP-1 and [125I]GLP-2 by a mechanism that involves glomerular filtration and tubular catabolism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085801     DOI: 10.1139/y90-239

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  15 in total

Review 1.  Gut adaptation and the glucagon-like peptides.

Authors:  D J Drucker
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

2.  Metabolic and endocrine functions of glucagon-like peptides - evolutionary and biochemical perspectives.

Authors:  T P Mommsen; E M Plisetskaya
Journal:  Fish Physiol Biochem       Date:  1993-07       Impact factor: 2.794

Review 3.  Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.

Authors:  G-R Martin; P-L Beck; D-L Sigalet
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

Review 4.  Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide.

Authors:  E Blázquez; E Alvarez; M Navarro; I Roncero; F Rodríguez-Fonseca; J A Chowen; J A Zueco
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

5.  Whey protein potentiates the intestinotrophic action of glucagon-like peptide-2 in parenterally fed rats.

Authors:  Xiaowen Liu; Sangita G Murali; Jens J Holst; Denise M Ney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-09-23       Impact factor: 3.619

6.  Influence of hemodialysis on incretin hormones and insulin secretion in diabetic and non-diabetic patients.

Authors:  Anna Masajtis-Zagajewska; Ilona Kurnatowska; Małgorzata Wajdlich; Marta Jagodzińska; Michał Nowicki
Journal:  Int Urol Nephrol       Date:  2013-05-14       Impact factor: 2.370

7.  Pharmacokinetics of teduglutide in subjects with renal impairment.

Authors:  Rüdiger Nave; Atef Halabi; Rolf Herzog; Peter Schaffer; Jörg Diefenbach; Stephan Krause; Peter Berghöfer; Gezim Lahu; Manfred Hartmann
Journal:  Eur J Clin Pharmacol       Date:  2012-11-28       Impact factor: 2.953

8.  Novel GLP-1 fusion chimera as potent long acting GLP-1 receptor agonist.

Authors:  Qinghua Wang; Kui Chen; Rui Liu; Fang Zhao; Sandeep Gupta; Nina Zhang; Gerald J Prud'homme
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

9.  Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels.

Authors:  Naro Ohashi; Naoko Tsuji; Yoshitaka Naito; Takamasa Iwakura; Shinsuke Isobe; Masafumi Ono; Tomoyuki Fujikura; Takayuki Tsuji; Yukitoshi Sakao; Hideo Yasuda; Akihiko Kato; Yoshihide Fujigaki
Journal:  Med Sci Monit       Date:  2014-04-10

Review 10.  Slow and steady is the key to beta-cell replication.

Authors:  Kristen Brennand; Doug Melton
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.